A connector assembly for use in a medical device system is provided. The connector assembly includes a female connector including a jack and at least one female electrical contact disposed in the jack, where the at least one female electrical contact includes an outer ring and leaf springs extending both radially inward from the outer ring and longitudinally along the jack. The connector assembly also includes a male connector including a plug adapted to be inserted into the jack of the female connector, and at least one male electrical contact disposed on the plug, where the at least one male electrical contact is configured to electrically couple to a corresponding female electrical contact of the at least one female electrical contact by contacting the plurality of leaf springs of the corresponding female electrical contact when the plug of the male connector is inserted into the jack of the female connector.

The application relates to a connection system for transmitting energy and/or data from and/or to an implantable blood pump. The proposed connection system comprises a first connection unit, which can be or is connected to the blood pump, and a second connection unit, which can be or is connected to a control and/or energy unit. In particular, the first connection unit can be connected to the blood pump by means of an implantable line. The second connection unit can be connected to the control and/or energy unit by means of a transcutaneous line. The first connection unit and the second connection unit can be wirelessly coupled to each other for wireless transmission of energy and/or data. Furthermore, the first connection unit and the second connection unit are implantable, so that both the first connection unit and the second connection unit are designed for use within the body of a patient.

The application relates to a connection system for transmitting energy and/or data from and/or to an implantable blood pump. The proposed connection system comprises a first connection unit, which can be or is connected to the blood pump, and a second connection unit, which can be or is connected to a control and/or energy unit. In particular, the first connection unit can be connected to the blood pump by means of an implantable line. The second connection unit can be connected to the control and/or energy unit by means of a transcutaneous line. The first connection unit and the second connection unit can be wirelessly coupled to each other for wireless transmission of energy and/or data. Furthermore, the first connection unit and the second connection unit are implantable, so that both the first connection unit and the second connection unit are designed for use within the body of a patient.

Described herein are devices and methods for pumping blood in a patient in need of circulatory assistance or a replacement heart. Instead of providing a temporary solution for these patients, the devices may be permanently implanted. The devices linearly reciprocate a shuttle within a housing to move blood into and out of the housing, and rotate the shuttle to selectively direct the movement of blood into and out of a plurality of ports in the housing.

Described herein are devices and methods for pumping blood in a patient in need of circulatory assistance or a replacement heart. Instead of providing a temporary solution for these patients, the devices may be permanently implanted. The devices linearly reciprocate a shuttle within a housing to move blood into and out of the housing, and rotate the shuttle to selectively direct the movement of blood into and out of a plurality of ports in the housing.

A ventricular assist device is disclosed. The ventricular assist device may include a centrifugal pump and a controller. The controller may be configured to cause the centrifugal pump to operate at a first speed above a predetermined flow rate. The controller may also be configured to cause the centrifugal pump to operate at a second speed below the predetermined flow rate, wherein the predetermined flowrate is indicative of a crossover point between systole and diastole phases of a person's cardiac cycle.

A ventricular assist device is disclosed. The ventricular assist device may include a centrifugal pump and a controller. The controller may be configured to cause the centrifugal pump to operate at a first speed above a predetermined flow rate. The controller may also be configured to cause the centrifugal pump to operate at a second speed below the predetermined flow rate, wherein the predetermined flowrate is indicative of a crossover point between systole and diastole phases of a person's cardiac cycle.

In some examples, a medical system includes a pump is configured to provide a pulsating blood flow. The pump may provide the pulsating flow to assist the pumping action of a heart. An impeller is configured to impart energy to the blood flow when the impeller rotates around an eye axis extending through an impeller eye defined by the impeller. The pump includes a magnetic bearing configured such that, as the impeller rotates around the eye axis, the eye axis translates around a post axis defined by a post mechanically supported by a pump housing. The medical system may include a controller configured to control a bearing magnetic field and/or a stator magnetic field to control a pressure of the pulsating flow and/or a speed of the pump.

The present document relates to a device for fixing a cardiac pump in an opening of a ventricular wall of a beating heart. The device includes: a hollow main body of overall cylindrical shape having an outer surface, this hollow main body includes a proximal end and a distal end between which said the outer surface extends, at least one portion of the outer surface of the main body intended to be placed inside ventricular cavity, except for its distal end, has a surface relief provided with protuberances and hollows, the distal end of the hollow main body forms a smooth crown having an arithmetic average roughness of less than or equal to 1 μm in order to stop the colonization of the fixing device by endothelial cells.

Materials and methods related to blood pump systems are described. These can be used in patients to, for example, monitor arterial pressure, measure blood flow, maintain left ventricular pressure within a particular range, avoid left ventricular collapse, prevent fusion of the aortic valve in a subject having a blood pump, and provide a means to wean a patient from a blood pump.